Enhabit, Inc. Files Definitive Proxy Statement
Ticker: EHAB · Form: DEFA14A · Filed: Jul 8, 2024
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, company-information
Related Tickers: ENHB
TL;DR
Enhabit (ENHB) filed its proxy statement, standard procedure for shareholder votes.
AI Summary
Enhabit, Inc. filed a Definitive Proxy Statement (DEFA14A) on July 8, 2024. The filing concerns information required for a proxy statement under Section 14(a) of the Securities Exchange Act of 1934. Enhabit, Inc. was formerly known as Encompass Health Home Health Holdings, Inc. until February 18, 2020.
Why It Matters
This filing is a standard regulatory requirement for public companies to provide shareholders with information necessary for voting on corporate matters.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) and does not contain new financial information or strategic decisions that would inherently increase risk.
Key Players & Entities
- Enhabit, Inc. (company) — Registrant
- Encompass Health Home Health Holdings, Inc. (company) — Former company name
- 0001803737-24-000112 (filing_id) — Accession Number
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing, or Definitive Proxy Statement, provides information required by the SEC for shareholders to make informed decisions when voting on corporate matters.
When was this DEFA14A filed by Enhabit, Inc.?
This DEFA14A filing was filed on July 8, 2024.
What was Enhabit, Inc.'s former name?
Enhabit, Inc.'s former name was Encompass Health Home Health Holdings, Inc.
What is Enhabit, Inc.'s primary business classification?
Enhabit, Inc. is classified under SERVICES-HOME HEALTH CARE SERVICES [8082].
Where is Enhabit, Inc. headquartered?
Enhabit, Inc. is headquartered at 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS, TX 75206.
Filing Stats: 4,115 words · 16 min read · ~14 pages · Grade level 13.6 · Accepted 2024-07-08 16:28:12
Key Financial Figures
- $10 million — dologies. AREX's assertion that another $10 million of cost cuts could be implemented with
Filing Documents
- ehab20240708defa14a-fl.htm (DEFA14A) — 65KB
- picture4a.jpg (GRAPHIC) — 22KB
- 0001803737-24-000112.txt ( ) — 96KB
Forward-Looking Statements
Forward-Looking Statements 3 AREX Investor Presentation, June 27, 2024. vendors', payors', and other contract counterparties' information systems, the outcome of litigation, our ability to successfully complete and integrate de novo locations, acquisitions, investments, and joint ventures, our ability to successfully integrate technology in our operations, our ability to control costs, particularly labor and employee benefit costs, and impacts resulting from the announcement of the conclusion of the strategic review process. Additional information regarding risks and factors that could cause actual results to differ materially from those expressed o